8-K: Elite Pharma Schedules Q2 FY2026 Earnings Call
Earnings Call Announcement
Elite Pharmaceuticals, Inc. announced it will host a conference call on November 17, 2025, to discuss its second quarter fiscal year 2026 financial results.
Summary
- Elite Pharmaceuticals, Inc. (OTCQB: ELTP) will release its second quarter fiscal year 2026 financial results, for the period ended September 30, 2025, on Friday, November 14, 2025.
- Management will host a live conference call on Monday, November 17, 2025, at 11:30 AM EST to discuss the financial and operating results and provide a general business update.
- Stockholders are encouraged to submit general questions by 5:00 PM EST on Thursday, November 13, 2025, and financial questions by 7:00 PM EST on Friday, November 14, 2025, via email to dianne@elitepharma.com.
Sentiment
Score: 5
Explanation: The filing is a neutral, procedural announcement regarding an upcoming earnings release and conference call, with no financial results or significant operational updates provided.
Risks
- Forward-looking statements involve risks, uncertainties, and other factors not under the control of Elite, which may cause actual results, performance, or achievements to be materially different from expectations.
- Risks include, without limitation, those related to the expected timing of approval, if at all, of products by the FDA and the actions the FDA may require of Elite to obtain such approvals.
Future Outlook
The press release contains standard forward-looking statements, cautioning that actual results may differ materially from expectations due to various risks and uncertainties, including those related to FDA product approvals. Elite is under no obligation to update or alter its forward-looking statements.
Management Comments
- Elite's management will host a live conference call on Monday, November 17th, at 11:30 AM EST to discuss the company's financial and operating results and provide a general business update.
Industry Context
Elite Pharmaceuticals, Inc. operates as a specialty pharmaceutical company focused on developing, manufacturing, and distributing niche generic products, including immediate-release and controlled-release solid oral dose products. This announcement is a standard procedural update for publicly traded companies in the pharmaceutical sector, providing transparency on upcoming financial disclosures.
Stakeholder Impact
- Shareholders and potential investors will receive an update on the company's financial performance and business operations during the upcoming conference call.
Next Steps
- Release of second quarter fiscal year 2026 financial results on November 14, 2025.
- Hosting a conference call on November 17, 2025, to discuss financial results and provide a business update.
Key Dates
| Date | Description |
|---|---|
| 2025-11-10 | Date of the 8-K report and press release issuance. |
| 2025-11-13 | Deadline for general questions for the conference call (5:00 PM EST). |
| 2025-11-14 | Release of second quarter fiscal year 2026 financial results. |
| 2025-11-14 | Deadline for financial questions for the conference call (7:00 PM EST). |
| 2025-11-17 | Conference call to discuss Q2 FY2026 financial results and provide a general business update (11:30 AM EST). |
Keywords
Elite Pharmaceuticals, ELTP, earnings call, financial results, Q2 2026, pharmaceutical, generic drugs, corporate update
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.